ID

34394

Beskrivning

A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms; ODM derived from: https://clinicaltrials.gov/show/NCT01309789

Länk

https://clinicaltrials.gov/show/NCT01309789

Nyckelord

  1. 2019-01-17 2019-01-17 -
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

17 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Lymphoma, Large-Cell, Anaplastic NCT01309789

Eligibility Lymphoma, Large-Cell, Anaplastic NCT01309789

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
treatment-naive cd30-positive mature t-cell and nk-cell neoplasms, including systemic anaplastic large cell lymphoma
Beskrivning

ID.1

Datatyp

boolean

measurable disease of at least 1.5 cm
Beskrivning

ID.2

Datatyp

boolean

ecog performance status less than or equal to 2
Beskrivning

ID.3

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
known cerebral/meningeal disease, including history of progressive multifocal leukoencephalopathy
Beskrivning

ID.4

Datatyp

boolean

current diagnosis of primary cutaneous anaplastic large cell lymphoma, mycosis fungoides, sezary syndrome or other primary cutaneous lymphomas; extranodal nk/t-cell lymphoma, nasal type
Beskrivning

ID.5

Datatyp

boolean

history of another primary malignancy that has not been in remission for at least 3 years
Beskrivning

ID.6

Datatyp

boolean

left ventricular ejection fraction <45% or symptomatic cardiac disease, or myocardial infarction within the past 12 months
Beskrivning

ID.7

Datatyp

boolean

viral, bacterial, or fungal infection within two weeks prior to the first dose of brentuximab vedotin
Beskrivning

ID.8

Datatyp

boolean

known human immunodeficiency virus (hiv), hepatitis b virus, or hepatitis c virus positive status
Beskrivning

ID.9

Datatyp

boolean

Similar models

Eligibility Lymphoma, Large-Cell, Anaplastic NCT01309789

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
treatment-naive cd30-positive mature t-cell and nk-cell neoplasms, including systemic anaplastic large cell lymphoma
boolean
ID.2
Item
measurable disease of at least 1.5 cm
boolean
ID.3
Item
ecog performance status less than or equal to 2
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
known cerebral/meningeal disease, including history of progressive multifocal leukoencephalopathy
boolean
ID.5
Item
current diagnosis of primary cutaneous anaplastic large cell lymphoma, mycosis fungoides, sezary syndrome or other primary cutaneous lymphomas; extranodal nk/t-cell lymphoma, nasal type
boolean
ID.6
Item
history of another primary malignancy that has not been in remission for at least 3 years
boolean
ID.7
Item
left ventricular ejection fraction <45% or symptomatic cardiac disease, or myocardial infarction within the past 12 months
boolean
ID.8
Item
viral, bacterial, or fungal infection within two weeks prior to the first dose of brentuximab vedotin
boolean
ID.9
Item
known human immunodeficiency virus (hiv), hepatitis b virus, or hepatitis c virus positive status
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial